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Magnetic resonance spectroscopic studies on 'real-time' changes in RIF-1
tumour metabolism and blood flow during and after photodynamic
therapy
J.C.M. Bremner, J.K. Bradley, I.J. Stratford & G.E. Adams
MRC Radiobiology Unit, Chilton, Didcot, Oxfordshire, OXJJ ORD, UK
Summary Magnetic resonance spectroscopy (MRS) in situ was used to study changes in 3'P metabolism
occurring during and after treatment of murine RIF-1 tumours with photodynamic therapy (PDT). Tumours
were irradiated using a fibreoptic light delivery system while the mice were in position within the magnet.
Changes in 3`P-MRS were observable during and immediately after treatments of several minutes' duration.
Both the extent and duration of the increase in the Pi/total ratio were light dose dependent. The effect on the
metabolism was also affected by the time interval (TL) between administering the photosensitiser disul-
phonated phthalocyanine, (AlS2Pc) and the light. With a dose of 50 J the increase in Pi/total was much faster
when TL was 1 h than when TL was 24 h. This difference in rate probably reflects differences in the
distribution of AlS2Pc within the tumour. Significant decreases in pH were only seen after a light dose of 50 J
when TL was 1 h. Blood flow measurements using deuterium uptake were also carried out using MRS. These
experiments showed that for a dose of 50 J the level of blood flow was reduced by approximately 90% of the
control value within 10 min from the end of the 8 min light treatment. This occurred irrespective of the value
of TL. The data indicate that it is possible to observe very early changes in 31P metabolism that can be
attributed to direct cellular damage as opposed to the later changes indicative of overall tumour hypoxia
caused by vascular damage.
Recently a study has been reported in which photodynamic
therapy (PDT) with disulphonated phthalocyanine (AlS2Pc)
was used, in combination with bioreductive drugs, to treat
the RIF-1 experimental murine tumour (Bremner et al.,
1992). It was found that the potentiation of the anti-tumour
effect was maximal when the time interval (TL) between
administration of the photosensitizer and light irradiation
was short (1 h). It was shown, using fluorescence imaging
techniques, that at 1 h the photosensitiser was almost totally
contained within the tumour vasculature, whereas at 24 h,
the time interval usually employed in PDT, it had diffused
into the surrounding tumour tissue. It was proposed that
treatment at the earlier time would cause more severe vas-
cular damage, thereby enhancing tumour hypoxia, and that
this would increase the effectiveness of bioreductive drugs.
PDT can cause cell death both by direct disruption of the
membranes and cellular organelles, e.g. mitochondria (Berns
et al., 1982; Grossweiner, 1984; Singh et al., 1987), and by
indirect damage caused by vascular occlusion, leading to
severe necrosis (Selman et al., 1984; Henderson et al., 1985).
The changes to the oxidative state of the cells can be
monitored using 31P magnetic resonance spectroscopy (MRS).
Ceckler et al. (1986), using 31P spectroscopy, observed a
decrease in ATP accompanied by an increase in the Pi peak
occurring by 1 h after treatment of rat R3230AC tumours.
Other workers, using the photosensitisers Photofrin II
(Chopp et al., 1987, 1990; Hilf et al., 1987; Chapman et al.,
1991) or chloraluminium sulphonated phthalocyanine (van
Bruggen et al., 1992) and a range of light doses, have
observed similar changes in the phosphorus metabolism in
various tumour and normal tissue models. Mattiello et al.
(1990) irradiated tumours 24h after the administration of
Photofrin II, while the mouse was in position within the bore
of the magnet. They used surface rather then interstitial
irradiation, which required a treatment time of 1 h. These
'real-time' studies showed significant increases in Pi and
decreases in intracellular pH occurring during the time of
irradiation. The pattern of changes in phosphorus meta-
bolism observed by all these investigators, accompanied in
some cases by changes in intracellular pH, are consistent with
the induction of tumour hypoxia.
The objective of the present study was to use 'real-time' 31P
magnetic resonance spectroscopy in situ to monitor changes
in phosphorus metabolism, pH and blood flow occurring
during PDT treatment and up to 24 h when TL was either
1 h or 24 h. The design of the experiments was such that
changes in metabolism could be observed during the maxi-
mum treatment time of 500 s and immediately thereafter.
Blood flow measurements using D20 uptake were taken before
and immediately after light irradiation, without disturbing
the position of the mouse within the bore of the magnet.
Owing to the non-invasive nature of the procedure, 3-4
uptake measurements can be taken for the same tumour.
Materials and methods
Tumour models
The RIF-1 murine sarcoma line was maintained as described
previously (Twentyman et al., 1980; Stratford et al., 1988).
Approximately 2 x 105 cells suspended in 0.05 ml of
phosphate-buffered saline (PBS) were implanted intrader-
mally (i.d.) into the mid-dorsal pelvic region of 8- to 10-
week-old C3H/He mice (category IV). The tumours were
sized by measuring in three orthogonal diameters (a, b and c)
at 2 day intervals. The volume was calculated as n/6 x abc
and the tumour volume at treatment was 100-200 mm3.
Each group consisted of at least five animals.
Photodynamic therapy
Photosensitiser The disulphonated aluminium phthalo-
cyanine (AlS2Pc) was synthesised, purified and supplied by
the Chemistry Department of Imperial College, London
(Ambroz et al., 1991). This compound was dissolved in
isotonic saline and administered intravenously (i.v.) The
injection volume was calculated to achieve a final dose in the
mouse of 4.37 mg kg-'.
Light source A Spectra Physics 2016 6 W argon-ion
pumped-dye laser was used to generate light at a wavelength
of 675 mm. The light was directed down a fibreoptic cable,
which ran directly from the laser facility to the nuclear
magnetic resonance (NMR) building. A 200-+m-core hard-
clad silica (HCS) single fibre with a ruggedised external
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sheathing was used. This was coupled to the laser light using
a multimode fibre coupler (Newport Corporation). The end
of this cable (230ym outer diameter) was cleaved and in-
serted interstitially into the centre of the tumour parallel to
the body of the mouse. Only one fibre was required for each
tumour.
The power density of the light, measured before insertion,
was 100mWcm2, and the duration of light exposure was
varied from 50 to 500 s to give a range of total light doses
between 5 and 50 joules (J).
For a group of six mice, tumour core temperatures were
measured during the light treatment. A thermocouple
(350 gim in diameter) was inserted into the centre of the
tumour facing the optic fibre and temperatures were
monitored every minute during a light dose of 100 mW for
500 s.
Treatment in the magnet bore
The time (TL) between the i.v. injection of AlS2Pc and the
administration of light was either 1 or 24 h. Prior to place-
ment in the magnet the mice were anaesthetised with a 1:1:2
mixture of Hypnorm-Hypnovel-water (0.1 ml i.p. per
mouse). The fibre was inserted into the tumour and the
mouse then positioned in the magnet where the light irradia-
tions were given. On removal from the magnet the mice were
wrapped in aluminium foil to restrict the amount of body
heat loss induced by the anaesthetic.
Nuclear magnetic resonance spectroscopy
All experiments were performed in a 4.7 tesla, 30 cm horizon-
tal bore superconducting magnet (Oxford Instruments) with
a SISCO 200 spectrometer (Varian Associates). An additional
tuning circuit was inserted into the radiofrequency line to
retune to the proton frequency (200.06 MHz) when shimming
the static magnetic field. Proton linewidths after shimming
were typically 50-60 Hz with corresponding 31P linewidths of
40-10O Hz and HDO linewidths of 20-30 Hz. Exponential
line-broadening (30 Hz) was applied before Fourier transfor-
mation. The body temperature of the mice in the magnet was
maintained at approximately 37°C by a circulating hot water
device positioned inside the magnet bore.
Phosphorus metabolism A two-turn 7-mm-diameter surface
coil was used, which fitted the diameters of the tumours and
allowed the measurement of signals down to a depth of
approximately 4 mm. The pulse width used, 7 ys, corres-
ponded to a 900 flip angle at the centre of the coil. Each
spectrum consisted of 256 acquisitions collected in 8 min 32 s,
using a 2 s repetition rate, 0.1 s acquisition time and spectral
width of 5,000 Hz. The spectra were analysed using a fitting
program, which approximated each line to a Lorentzian
shape of an irregular baseline. After fitting the baseline and
then each spectral line by eye, the programme optimised the
fit by the least-squares method. The area under each peak
relative to the area under the methylenediphosphonic (MDP)
acid reference peak was calculated and the ratio of the
inorganic phosphate area to the area under all the peaks (Pi/
total) was used to indicate the changes occurring in the
spectra. The time points on graphs correspond to the mid-
point of the collection time.
For light doses of 50 J when the duration of treatment was
500 s, it was possible to accumulate spectra during irradia-
tion. For lower light doses, spectra were collected
immediately after the end of light illumination and subse-
quently at 10 min intervals for 1 h. A control spectrum was
collected for all tumours prior to light irradiation. At 24 h
following treatment the mice were lightly restrained, without
anaesthetic, in Perspex jigs and replaced in the centre of the
magnet for a final spectrum to be collected.
For statistical analysis, a Student's t-test was used to
obtain a comparison of treated and control groups.
pH measurements The frequency shift between the Pi peak
and either the y- or a-ATP peaks was used to calculate pH
using the Hasselbalch equation. Measurements ofpH became
increasingly unreliable as the ATP peaks decreased after
treatment. Measurements were restricted to values of Pi total
of about 0.4 or less.
Deuterium (D20) uptake measurements A five-turn, 1 cm
solenoid coil was used as transmitter and receiver. From
images obtained with this coil it was estimated that 90% of
the signal is received from a depth of less than 4 mm,
indicating that the measurements relate to the tumour and
not to underlying tissue. Spectra were acquired with a pulse
width of 18 iLs, chosen to maximise the signal intensity under
the experimental conditions of the ratio of repetition rate to
T, relaxation time, a spectral width of 2,500 Hz and acquisi-
tion time of 0.1 s. Each spectrum contained the averaged
data from 75 scans at a repetition time of 0.2 s and was
acquired in 15 s. For each uptake measurement an array of
60-70 spectra was collected in 15-20 min. In the mouse D20
becomes a tracer molecule (HDO) through the rapid exchange
of protons. Relative HDO concentrations were estimated
from the height of the HDO peak.
A cannula (Jelco, 24 gauge) rinsed with heparin and con-
nected to modified 125 cm silicone paediatric duodenal tub-
ing (Vygon UK) was inserted into the tail vein. The tubing
was filled with D20 [0.9% (w/v) sodium chloride] and con-
nected to a 1 ml syringe. The mice were positioned in the
magnet with the syringe outside the magnet bore. Five com-
plete spectra were obtained before injecting 70 tlI of D20
during the sixth scan. Spectra were then acquired every 15 s
for up to 20 min. Control HDO uptake was measured
immediately before light irradiation and then further
measurements were made 5, 30, 60 min and 24 h after treat-
ment.
D20 data analysis The uptake curve obtained was fitted to a
monoexponential curve of the form q(t) = [q(O)-q(oo.)exp(-
k,t) + q(ao)], where k is a first-order rate constant and q(O)
and q(oo) are the initial and final intensities of the deuterium
signal. The deuterium in the blood system equilibrated within
30s post i.v. injection (Pearson et al., 1992) and the data
were fitted from t = 30 s to 15 min. The rate of uptake
described by the rate constant cannot be used to give an
absolute measure of tumour blood flow (TBF) without
knowing the form of the arterial output function, so only
changes in the TFB relative to its own control were used.
The time points on the graphs correspond to the midpoints
of the collection times.
Results
Changes inphosphorus metabolism andpH
Figure 1 shows an example of "P spectra obtained from the
RIF-1 tumour before (a), during (b), immediately after (c)
and 30 min after (d) PDT treatment with 50 J and a TL of
1 h. Changes in the Pi and ATP peaks occur even during the
8.5 min of treatment. The Pi peak continues to increase and
the ATP peaks decrease until the Pi total ratio is either
greater than or equal to 0.4. At this ratio the ATP peaks are
almost indistinguishable from the background. An increase
above this level is due mainly to changes in the ratio of Pi to
Pmie (phosphomonoester) and not to a further decrease in the
ATP.
In Figure 2 the Pi total ratio is plotted against the time
after the end of light treatment for doses of 5-50J. For
tumours receiving either 5 or 7.5 J the Pi total ratio showed a
small but significant increase (P<0.05) above the control
and remained at this level for at least 64 min. By 24 h post
treatment these ratios had returned to the control value.
Doses of 10 and 30 J caused much larger increases
(P< 10-1) in the Pi total ratio, and both reached a max-
imum level of approximately 0.3 at 64 min post treatment.
The ratios were still significantly (P<0.01) above control
values 24 h after the end of treatment. The greatest changesCHANGES IN METABOLISM AND BLOOD FLOW AFTER PDT 1085
in the phosphorus metabolism were observed after the max-
imum dose of 50 J, when a Pi/total ratio of 0.4 was reached
24 min after the end of treatment (P< 1010) and was main-
tained at this level for at least 24 h.
The tumour pH calculated from the displacement of the
a-ATP peak from the Pi peak is shown in Table I (control
pH, is 7.2 ± 0.2, n = 16). The same calculations were also
Figure 1 A sample 31p spectrum obtained from the RIF-1
tumour before a, during b, immediately after c and 30 min after d
PDT treatment. The light dose is 50 J and TL is 1 h. The peaks
identified are: 1, the external reference peak, MDP; 2, Pme; 3, P.;
4, y-ATP; 5, a-ATP; 6, P-ATP.
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Figure 2 Changes in 31P metabolism occurring after different
light doses are demonstrated by plotting the Pi/total ratio as a
function of time after the end of light treatment, where TL is 1 h.
The light doses are 5J (A), 7.5J (A), 10J (O), 30J (V) and
50 J (*). There are between five and seven animals in a group
and each point represents the mean ± s.e.m. The shaded box
represents the control values for AlS2Pc alone, which do not
differ from untreated controls.
carried out using the y-ATP peak, and very similar results
were obtained. For doses of 5-30 J, the pH values show no
significant change following treatment. However, a significant
pH drop of about 0.4 pH units occurs within 4min of treat-
ment with 50 J and is maintained for at least 20 min
(P < 10-4).
Figure 3 shows the effect on the phosphorus metabolism
when the interval (TL) between the administration of the
sensitiser and the light is increased from 1 to 24 h. For doses
of both 10 and 50 J, a much greater change in the Pi/total
ratio is observed for the TL value of 1 h. At the lower dose,
there is no significant increase above the control value when
TL is 24 h, whereas for the 1 h interval the ratio increased to
over 0.3 by 24min. At the higher dose of 50J, when an
increase of Pi/total is observed for both values of TL, the
curve rises much more slowly for the 24 h interval than for
the TL of 1 h.
The influence of TL on the extent of the change in the
phosphorus metabolism is also reflected by the effect of TL
on the pH changes induced by PDT. Figure 4 shows that, for
TL = 24 h, there is no effect of treatment on pH for up to
64 min post treatment, notwithstanding the significant
changes in Pi/total that is observed for this dose of 50 J when
TL was 1 h. The data in Figure 4 for TL = 1 h include values
from Table I.
During the 500 s of light irradiation for the 50 J dose, the
tumour core temperature rose from the anaesthetised control
value of 33.5 ± 0.7°C to 37.3 ± 0.6°C. As can be seen from
Figure 3b, a light dose of 50 J given alone did not affect the
31P metabolism in the RIF-l tumour. No charring of the fibre
tips was observed (the effect of charring on light emission
from fibre tips has been discussed by Driver et al., 1989).
Although the light distribution within tissues is reported to
be non-uniform (see Star et al., 1992), the small size of the
tumours used in this study and the relative structural
homogeneity of the RIF-1 tumour should reduce the prob-
lems of the inhomogeneous light distribution.
Relative changes in tumour bloodflow
The changes in D20 uptake measurements after a dose of
50J for TL of 1 and 24h are shown in Figure 5. The
ordinate gives changes in the uptake rates of 2H for each
mouse relative to its own control. The data indicate changes
in TBF. There is a drop in blood flow to around 9% of the
control value in the first 10min after treatment for both
values of TL. There is a suggestion that a small rise in this
value from 9 to 20% occurs during the first hour post
treatment when TL is 24 h.
Discussion
In the present MRS study using interstitial light irradiation it
was possible to irradiate the tumours while they were situated
within the bore of the magnet, thus allowing changes in the
phosphorus metabolism of the RIF-I tumour to be
monitored immediately after and, in the case of the 50 J
dose, during the 8 min of PDT treatment.
The rapid increase in the Pi/total ratio observed after a
light dose of 50 J occurred irrespective of whether TL was 1
or 24 h. However, for the shorter TL interval, the time taken
Table I Change in pH values 4 and 20 min post light irradiation for the RIF-1 tumour. The pH is
determined using the displacement of either the a- or y-ATP peaks from the Pi peak. The
mean ± s.e.m. of the difference in pH from its own control value has been calculated
ApH
Light dose 4 min after light 20 min after light
(joules) a Y a Y
5 -0.07 0.11 -0.07 0.05 0.00±0.08 - 0.04 0.04
7.5 -0.15 0.12 -0.10 0.06 0.08 0.09 -0.08 0.07
10 -0.14±0.09 -0.18±0.98 -0.14±0.17 -0.13±0.09
30 -0.18 0.10 -0.25 0.08 -0.16 0.09 -0.09 0.8
50 -0.48 0.15 -0.43 0.21 - 0.44 0.11 - 0.30 0.10
a b
2,,,} 3>~ 6N '<, Yl\J\\yKN..1086 J.C.M. BREMNER et al.
0.7 ~~~~~~~~~~~~0.7
0.6 Q1
0.5 0.5
0.4 0.4
0.3 f { f- 0.3
0.2 ~ ~ ~ ~ ~~~f0.2
O 0 - . , ~ ' p . --- a 0---_--
0 10 20 30 40 50 60 70 24 0 10 20 3
Time after start oftreatment (min)
30 40 50 60 70 24
Figure 3 Showing the effects on 31p metabolism with time after light doses of 1O J a or 50 J b when TI is I h (V) or 24 h (-).
Data for light alone (50 J) are also shown (0). There are between five and seven animals in a group and each point represents the
mean ± s.e.m. The vertical hatched box indicates the duration of treatment. The horizontal hatched box indicates the control values
for A1S2Pc alone, which do not differ from untreated controls.
al ratio to increase to its final plateau value was due to both the different tumour models and the photosen-
Dn TL was 24 h. Similarly the very rapid change sitisers used in the two studies.
H occurred only when TL was 1 h. This change The influence of hyperthermia can be assumed to be unim-
of a pH unit is evident for at least 30 min post portant in this study as the maximum PDT light dose (50 J)
nt. Chopp et al. (1987) also examined the effect used did not produce temperatures considered to be hyper-
'L on PDT-induced changes in 31P metabolism thermic. Light alone was shown not to affect the 31P
)bserve any effect of varying TL from 30 min to metabolism in the RIF-I tumour.
parent difference in the reported results may be In the RIF-1 tumour the photosensitiser is confined to the
tumour vasculature when TL is 1 h but has diffused out into
the surrounding tumour tissue by 24 h (Bremner et al., 1992).
Therefore the two patterns of behaviour may reflect the
different consequences of PDT on two distinct cellular
populations, i.e. the cells within, and very close to, tumour
endothelium or the tumour cells lying in the intervascular
regions. The more pronounced 31p changes observed when
TL was 1 h compared with 24 h could be due to differences
in the metabolic status of the cells affected by the PDT at the
different time intervals. The tumour vasculature and the sur-
rounding cells are likely to be more oxygenated than cells
distant from the vasculature, which are presumed to be less
metabolically active. As the oxygenated cells would be pro-
ducing the greater proportion of ATP observed using 31p_
MRS, when these cells were killed or injured by PDT
ntrol 10 20 30 40 50 (TL = 1 h) the effect on the 31P spectra should be larger and therefore detectable than when the less metabolically active Time after end of treatment (min) cells are targeted (TL = 24 h).
emonstrating the effect on the pH. of the RIF-l Reduction of blood flow following a 50 J light dose is
a PDT light dose of 50J when TL is I h (V) or substantial and very rapid irrespective of whether TL is I or
ch point represents the mean ± s.e.m. ofat least four 24 h. Therefore both types of treatment should increase the
's. The control pH for the tumours determined after severity of tumour hypoxia. It is noteworthy that within
prior to light is also shown for the two groups. 20min after the start of treatment tumour blood flow is
l2or
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Figure 5 Changes in blood flow as measured by deuterium uptake are shown against time after the start of a 50 J light treatment
when TL is 1 h a, or 24 h b. The change in uptake rate is plotted as a percentage of the control value. There are between five and
seven animals in a group, and each point represents the mean ± s.e.m. The dotted lines indicate the increases in Pi/total ratios for
the same time course, data for which are taken from Figure 3.
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reduced by approximately 80-90% for both values of TL
but the Pi/total ratio is greater when TL is 1 h. This is
consistent with the induction of direct damage to
metabolically active cells when the photosensitiser is mainly
confined to the vasculature. This could cause a reduction in
ATP as a result of damage to mitochondria and/or other
organelles, which would be followed by additional changes in
phosphorus metabolism occurring throughout the tumour re-
sulting from oxygen depletion due to blood vessel destruction.
In PDT studies using Photofrin II, Mattiello et al. (1990)
speculated on the possibility of distinguishing between direct
and indirect mechanisms of cell death, using 3"P-MRS. The
fast time resolution available in the present study with
AlS2Pc, together with the information on drug distribution,
indicates that direct damage to the vasculature and surround-
ing cells can be detected at a very early stage. In the RIF-l
tumour (J.C.M. Bremner, unpublished results; see also
Adams et al., 1992), changes in the phosphorus metabolism
caused by occlusion of the tumour blood supply by clamping
occur more slowly than those occurring after PDT when TL
is 1 h. This again suggests that the very early changes occurr-
ing when TL is 1 h may result from direct organelle disrup-
tion and not just vascular damage.
There is, for a TL of 1 h, a clear effect of light dose on
tumour metabolism with a threshold of between 7.5 and 10 J.
For higher doses, the Pi/total ratios reach a maximum value
by about 20-30 min post treatment and are maintained for
at least an hour. For the highest dose of 50 J, the ratio is still
high 24 h post treatment but has decreased significantly by
this time for the treatments of 10 and 30 J. This indicates
that the damage induced by 50 J is more extensive, and
therefore less recoverable, than that occurring after the lower
doses. The conclusion that a greater degree of hypoxia was
induced by the higher dose is substantiated by other tumour
regrowth studies carried out in the RIF-I tumour with
bioreductive drugs (Bremner et al., 1992).
In conclusion, MRS can be used to determine both the
very early changes occurring in tumour metabolism and the
differences resulting from the use of varying PDT protocols.
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